rethinkTHC Search
Menu
Study breakdown

Boosting endocannabinoid 2-AG protected against stomach bleeding caused by common painkillers in mice

Animal StudyPreliminary evidence
The takeaway

The MAGL inhibitor JZL184 prevented NSAID-induced gastric hemorrhages in mice as effectively as the proton pump inhibitor omeprazole, working through the CB1 receptor without developing tolerance.

Read this if you are interested in how the endocannabinoid system could protect the stomach from painkiller damage.

MAGL inhibitor matched standard gastroprotection without tolerance

What the researchers found

NSAIDs (common painkillers like ibuprofen) frequently cause stomach bleeding and ulcers. Researchers tested whether boosting levels of the endocannabinoid 2-AG by inhibiting its breakdown enzyme MAGL could protect the stomach.

In mice given the NSAID diclofenac, the MAGL inhibitor JZL184 significantly prevented gastric hemorrhages, as effectively as the proton pump inhibitor omeprazole (a standard gastroprotective drug) and THC.

JZL184 also completely blocked diclofenac-induced increases in pro-inflammatory cytokines (IL-1-beta, IL-6, TNF-alpha) in stomach tissue. The protective effect worked through CB1 receptors specifically, as shown by both pharmacological blockade and genetic knockout experiments.

Importantly, the gastroprotective effects of JZL184 persisted with repeated administration, showing no tolerance development.

Why it matters

NSAIDs cause significant GI complications. A gastroprotective agent based on the endocannabinoid system could potentially be combined with NSAIDs to prevent stomach damage while maintaining pain relief.

The numbers in context

JZL184 matched omeprazole and THC effectiveness. Completely blocked diclofenac-induced increases in IL-1-beta, IL-6, TNF-alpha, and G-CSF. Gastroprotection mediated by CB1 (not CB2). No tolerance with repeated dosing.

How the study worked

Controlled animal study in mice. Diclofenac-induced gastric hemorrhage model. JZL184 (MAGL inhibitor), omeprazole, and THC tested as interventions. Inflammatory cytokines measured. CB1 and CB2 receptor involvement tested using antagonists and knockout mice. Repeated dosing tested for tolerance.

What this study cannot tell us

Mouse model. JZL184 is a research tool not approved for human use. Only one NSAID (diclofenac) tested. Long-term safety of MAGL inhibition in the GI tract is unknown.

How to read the evidence

Well-designed animal study with mechanistic validation using knockouts and antagonists, but limited to mouse models.

When this study was published

Published in 2011. MAGL inhibitor drug development has continued.

The bigger picture

MAGL inhibition could potentially produce analgesics with built-in gastroprotective properties, addressing a major limitation of current NSAID therapy.

Questions still open

  • Could MAGL inhibitors be developed as dual analgesic-gastroprotective drugs? Would the gastroprotective effect translate to humans?

Common questions

Could endocannabinoids protect the stomach from painkiller damage?
In mice, boosting the endocannabinoid 2-AG protected against stomach bleeding from NSAIDs as effectively as standard gastroprotective drugs, working through CB1 receptors and blocking inflammatory cytokines.
What is MAGL?
MAGL (monoacylglycerol lipase) is the enzyme that breaks down 2-AG, one of the body's main endocannabinoids. Blocking MAGL increases 2-AG levels, boosting the endocannabinoid system's protective effects.

Read the original research

Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice.

The Journal of pharmacology and experimental therapeutics, 338(3), 795-802

Citation

Kinsey, Steven G; Nomura, Daniel K; O'Neal, Scott T; Long, Jonathan Z; Mahadevan, Anu; Cravatt, Benjamin F; Grider, John R; Lichtman, Aron H. (2011). Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice.. The Journal of pharmacology and experimental therapeutics, 338(3), 795-802. https://doi.org/10.1124/jpet.110.175778

Explore the wider topic